PC522
Anti-Adenine Nucleotide Translocase-1 (Ab-1) (2-11) Rabbit pAb
liquid, Calbiochem®
Synonym(s):
Anti-ANT-1
biological source
rabbit
antibody product type
primary antibodies
clone
polyclonal
form
liquid
does not contain
preservative
species reactivity
human
manufacturer/tradename
Calbiochem®
storage condition
OK to freeze
avoid repeated freeze/thaw cycles
isotype
IgG
shipped in
dry ice
storage temp.
−20°C
General description
Anti-Adenine Nucleotide Translocase-1 (Ab-1) (2-11), rabbit polyclonal, recognizes ~35 kDa ANT-1 in doxorubicin-treated MCF-7 cells. It is validated for WB, immunofluorescence, and paraffin sections.
Purified rabbit polyclonal antibody. Recognizes the ~35 kDa ANT-1 protein.
Recognizes the ~35 kDa ANT-1 protein in doxorubicin-treated MCF-7 cells or breast carcinoma tissue.
- Antibody Target Gene Symbol: ANK3
- Target Synonym: 2900054D09RIK, AI314020, AnkG, Ankyrin-3, ANKYRIN-G, FLJ45464, MGC14049
- Entrez Gene Name: ankyrin 3, node of Ranvier (ankyrin G)
- Hu Entrez ID: 288 (Related Antibodies: NB20, AP1034, PC523, AP1057)
- Mu Entrez ID: 11735
- Rat Entrez ID: 361833
Immunogen
Human
a synthetic peptide corresponding to amino acids 2-11 of human ANT-1
Application
Immunoblotting (2.5 g/ml, chemiluminescence)
Immunofluorescence (1 g/ml)
Paraffin Sections (1 g/ml, heat pre-treatment required)
Packaging
Please refer to vial label for lot-specific concentration.
Physical form
In 50 mM sodium phosphate buffer, 50% glycerol.
Preparation Note
Following initial thaw, aliquot and freeze (-20°C).
Analysis Note
Positive Control
doxorubicin-treated MCF7 cells, or breast carcinoma tissue
doxorubicin-treated MCF7 cells, or breast carcinoma tissue
Other Notes
Bauer, M.K.A., et al. 1999. J. Cell Biol.147, 1493.
Marzo, I, et al. 1998. Science281, 2027.
Marzo, I, et al. 1998. J. Exp. Med.187, 1261.
Zoratti, M. and Szabo, I. 1995. Biochim. Biophys. Acta1231, 139.
Klingenberg, M. 1993. J. Bioenerg. Biomembr.25, 447.
Riccio, P., et al. 1975. FEBS Lett.56, 133.
Marzo, I, et al. 1998. Science281, 2027.
Marzo, I, et al. 1998. J. Exp. Med.187, 1261.
Zoratti, M. and Szabo, I. 1995. Biochim. Biophys. Acta1231, 139.
Klingenberg, M. 1993. J. Bioenerg. Biomembr.25, 447.
Riccio, P., et al. 1975. FEBS Lett.56, 133.
MCF7 cells treated with doxorubicin at 0.2 µg/ml for 24 h can be used as positive control for immunoblotting. Antibody should be titrated for optimal results in individual systems.
Legal Information
CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany
Disclaimer
Toxicity: Standard Handling (A)
Not finding the right product?
Try our Product Selector Tool.
Regulatory Information
新产品
This item has
Certificates of Analysis (COA)
Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service